Biofrontera (BFRI) Change in Accured Expenses (2020 - 2025)

Biofrontera's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$1.7 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 321.32% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $610000.0 (up 365.22% YoY), while the FY2025 annual figure was $610000.0, up 365.22% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$1.7 million, down from $746000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $3.1 million in Q2 2023, with the low at -$6.5 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is -$313500.0 (2022), against an average of -$517550.0.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses jumped 638.12% in 2022, then slumped 321.32% in 2025.
• Biofrontera's Change in Accured Expenses stood at -$1.1 million in 2021, then sank by 213.69% to -$3.4 million in 2022, then tumbled by 93.1% to -$6.5 million in 2023, then surged by 93.98% to -$394000.0 in 2024, then plunged by 321.32% to -$1.7 million in 2025.
• Business Quant data shows BFRI's Change in Accured Expenses at -$1.7 million in Q4 2025, $746000.0 in Q3 2025, and $1.2 million in Q2 2025.